|
Title
|
|
|
|
EORTC Imaging Group
| |
|
Author
|
|
|
|
| |
|
Institution/Organisation
|
|
|
|
EORTC Imaging Group
| |
|
Abstract
|
|
|
|
| Imaging data have the potential to provide information on disease profiling pertaining to diagnosis, prognosis, selection of therapy, monitoring of response to therapy and pharmacokinetic information of drugs. Selection of the most appropriate imaging modality for a specific task will be vital for diagnosis, stratification, treatment response or treatment efficacy, toxicity assessment, and treatment outcome measures (progression-free survival). The EORTC Imaging Group was formed to establish and maintain the scientific and clinical value of advanced imaging in EORTC clinical trials. The group focuses on the development of specific analytical and review procedures as well as quality control procedures, in the context of clinical trials conducted by the EORTC groups. (C) 2012 European Organisation for Research and Treatment of Cancer. All rights reserved. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
European journal of cancer : supplements. - Amsterdam, 1990, currens
| |
|
Publication
|
|
|
|
Amsterdam
:
2012
| |
|
ISSN
|
|
|
|
1359-6349
[print]
1878-1217
[online]
| |
|
DOI
|
|
|
|
10.1016/S1359-6349(12)70015-0
| |
|
Volume/pages
|
|
|
|
10
:1
(2012)
, p. 82-87
| |
|
ISI
|
|
|
|
000302130800013
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|